Home > Press > BBI partners with NIST to develop the 'Gold Standard' in nanoparticles
Abstract:
BBInternationalís gold nanoparticles have been selected by the National Institute of Standards and Technology (NIST) as the source for a series of certified reference materials for pre-clinical biomedical research.
NIST, which is a US federal agency, will use BBnternational's colloidal gold nanoparticles to create nanoscale reference materials for the evaluation and qualification of methodology and instrument performance. This means that companies involved in the fields of research and diagnostics will be able to ensure that their equipment is performing within the required QC parameters for the measurement and characterisation of quality nanoparticles.
BBInternational has been a leading global provider of gold nanoparticles to the life science and diagnostic industries since 1986, with customers relying on the companyís stringent quality assurance procedures for consistent stability and reproducibility. BBInternational's proprietary manufacturing technique allows the consistent production of large volumes of highly spherical, mono disperse gold nanoparticles in pre-determined sizes, which are widely used in rapid lateral flow assays.
Commenting on the collaboration, Lyn Rees, CEO of BBInternational's Diagnostics Division said:
"We are delighted that our gold has been recognised by NIST as the reference standard in this category. Everything we do at BBI is governed by quality and this collaboration with NIST further supports the 'Gold Standard' reputation that BBI gold has worked hard to achieve within the industry. We look forward to working with NIST in communicating this message, and supporting the industry with our expertise in the field."
BBInternational's gold colloid is produced using a unique recipe and quality process which allows production of gold colloid in pre-determined sizes, with optimum roundness, uniform shape, and less than 8% CV for cluster free, stable gold to enhance sensitivity and performance. The company has built a strong customer base throughout the world providing reagents and services to a client base spanning small universities through to blue chip diagnostic industry leaders.
####
About BBInternational
For further information on BBInternational's products and OEM diagnostic services, contact the company on +44 (0) 29 2074 7232 or e-mail . Details on the range of technological standards and reference materials offered by NIST can be found on www.NIST.gov/srm
About NIST
Founded in 1901, NIST is a non-regulatory federal agency within the US Department of Commerce. NIST's mission is to promote U.S. innovation and industrial competitiveness by advancing measurement science, standards, and technology in ways that enhance economic security and improve quality of life.
For more information, please click here
Contacts:
Lisa Cook
+44 (0) 29 2074 7232
Copyright © BBInternational
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||